Dr. Martens has reported strong sales growth in its results for the year to March 31st.
The company achieved 25% growth in group revenue to £290.6 million. Additionally, there was a 38% increase in retail revenue to £78.9 million. EBITDA was up 27% to £37.5 million in the period following investment in new stores, ecommerce and new products.
Chairman of Dr. Martens, Paul Mason said: “Despite a challenging retail environment, we have delivered double digit growth across all areas of the business and continue to see the investments in our people, structure and operations as an integral part of our aim to deliver long-term sustainable growth. The strong performance we have seen demonstrates that our strategy is the right one.”
